Funder
Javna Agencija za Raziskovalno Dejavnost RS
European Regional Development Fund
Reference33 articles.
1. Agency, E.C., 2022. Appendix for nanoforms to the guidance on registration and the guidance on substance identification: version 2.0 January 2022. https://data.europa.eu/doi/10.2823/40 (accessed 8.8.2023).
2. Azarsiz, E., Karaca, N., Ergun, B., Durmuscan, M., Kutukculer, N., Aksu, G., 2018. In vitro T lymphocyte proliferation by carboxyfluorescein diacetate succinimidyl ester method is helpful in diagnosing and managing primary immunodeficiencies. J. Clin. Lab. Anal. 32.
3. Casula, L., Zidar, A., Kristl, J., Jeras, M., Kralj, S., Fadda, A.M., Zupančič, Š., 2023. Development of nanofibers with embedded liposomes containing an immunomodulatory drug using green electrospinning. Pharmaceutics 15, 1245-1264.
4. Corporation, P., 2016. TECHNICAL BULLETIN CytoTox 96® Non-Radioactive Cytotoxicity Assay Instructions for Use of Product G1780, www.promega.com/protocols/.
5. In vitro and in vivo ocular biocompatibility of electrospun poly(ɛ-caprolactone) nanofibers;Da Silva;Eur. J. Pharm. Sci.,2015